Key result
Percutaneous aortic balloon valvuloplasty acutely lowers mean gradient, but restenosis recurs by ~6 months.
Why the study?
The short-term results and clinical outcomes of percutaneous aortic balloon valvuloplasty in elderly high-risk patients with severe calcific aortic stenosis were evaluated.
Does percutaneous aortic balloon valvuloplasty improve echocardiographic and clinical outcomes in elderly patients with symptomatic, severe aortic stenosis at high surgical risk?
Observational (n=55)
Does percutaneous aortic balloon valvuloplasty improve echocardiographic and clinical outcomes in elderly patients with symptomatic, severe aortic stenosis at high surgical risk?
Percutaneous aortic balloon valvuloplasty in high-risk elderly patients with severe aortic stenosis provides initial hemodynamic improvement that is frequently lost at short-term follow-up due to restenosis, though a subset experiences sustained clinical benefit.
Answers are grounded in this paper and cite their sources.
High short-term mortality and reinterventions after balloon valvuloplasty in high-risk elderly patients; leaves open its comparative role versus surgery in prospective trials.
To evaluate the short-term results of percutaneous aortic balloon valvuloplasty, 55 consecutive elderly patients with symptomatic, severe aortic stenosis who were at high risk for surgical intervention underwent the procedure, with follow-up by clinical evaluation and Doppler echocardiography. Over a mean follow-up of 6.2 months, there were three early deaths (less than 30 days) and eight late deaths. Nine patients underwent subsequent aortic valve surgery, and four had repeat balloon valvuloplasty. Doppler echocardiography revealed a reduction in aortic valve mean gradient from 48 +/- 18 to 33 +/- 12 mm Hg after the procedure (p less than 0.0001) but a return to 46 +/- 16 mm Hg at follow-up (p less than 0.05). The aortic valve area increased from 0.54 +/- 0.15 to 0.85 +/- 0.23 cm2 after the procedure (p less than 0.0001), but there was a significant decrease to 0.67 +/- 0.19 cm2 at follow-up (p less than 0.05). Of patients free of aortic valve operation or death after 30 days after the procedure, 76% were severely symptomatic before the procedure as compared with 38% at follow-up. In patients undergoing percutaneous aortic balloon valvuloplasty, there is a continued high short-term mortality and a significant incidence of restenosis over short-term follow-up. Nonetheless, a subset of patients do experience sustained clinical improvement from this procedure.
No takes yet. Share an insight, caveat, or question.
Nishimura et al. (1988) conducted an observational in calcific aortic stenosis (n=55). Percutaneous aortic balloon valvuloplasty was evaluated on Aortic valve mean gradient (p=<0.0001). Percutaneous aortic balloon valvuloplasty initially reduced aortic valve mean gradient, but restenosis occurred at 6.2 months with gradient returning to 46 mm Hg.
Synapse has enriched 10 related papers. Consider them for comparative context: